We fight cancer for you.
Neuboron, established in 2014 in Nanjing, China, is the most promising BNCT total solution provider as well as the developer of the accelerator-based BNCT (AB-BNCT) system, treatment planning system, Monte-Carlo based dose engine, and tumor-targeting boron carriers, among others. Neuboron has deployed over 500 patented and intellectual property protected technologies in its BNCT total solution.
Be light Be salt, Treat patients as our family.
Pioneer in AB-BNCT industry, leader in global technological innovation.
Make a real CHANGE in cancer treatment.
Clinical transformation
Preparation for clinical research
Partnered Overseas project
Industrialization
The 1st AB-BNCT Center in China started construction
Partnered with Shanghai Renji Hospital
The 1st AB-BNCT Center
Partnered with Xiamen Humanity Hospital and C&D Group to build the 1st AB-BNCT Center in China.
Global Patent applications exceed 300.
Cooperation
Partnered with TAE Life Sciences and Yantai Dongcheng pharmaceutical Group
China Key Project for Digital Medical Equipment granted.
Core technology
AB-BNCT system design accomplished.
Partnered with CNAO and INFN (Italy).
China-Italy Joint National Key Project granted.
Development
BPA and F-BPA successfully developed.
Patent layout strategy started.
Founded
Neuboron Setup in Nanjing, China.
Core members from THOR (Tsing-Hua Univ.)
2015：Development
BPA and F-BPA successfully developed.
Patent layout strategy started.
